ABO Blood Group and Risk of Pancreatic Carcinogenesis in Intraductal Papillary Mucinous Neoplasms.
Tsuyoshi HamadaHiroki OyamaYousuke NakaiMinoru TadaHideo KohKeisuke TateishiJunichi AritaRyunosuke HakutaHideaki IjichiKazunaga IshigakiYoshikuni KawaguchiHirofumi KogureSuguru MizunoTeppei MorikawaKei SaitoTomotaka SaitoTatsuya SatoKaoru TakagiNaminatsu TakaharaRyota TakahashiAtsushi TanakaMariko TanakaTetsuo UshikuKiyoshi HasegawaKazuhiko KoikePublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2021)
ABO blood group can be a biomarker for pancreatic cancer risk among patients with IPMNs.
Keyphrases